Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

NHFOV vs nCPAP in Very Preterm Infants With Respiratory Distress Syndrome: A Multi-center, Prospective, Randomized, Controlled Clinical Superior Trial

NCT05141435 is registered in ClinicalTrials.gov with Jiulongpo No.1 People's Hospital as lead sponsor.

NCT NCT05141435
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05141435 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
NHFOV vs nCPAP in Very Preterm Infants With Respiratory Distress Syndrome: A Multi-center, Prospective, Randomized, Controlled Clinical Superior Trial
Lead sponsor
Jiulongpo No.1 People's Hospital
Phase
Not applicable
Overall status
Completed
Start date
August 1, 2022
Completion date
August 5, 2024
Enrollment
360 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

to test the hypothesis that nhfov is more effective than ncpap in the treatment of respiratory distress syndrome (rds) in verypreterm neonates